IDXX vs WAT — Key Metrics

Metric IDXX (IDEXX LABORATORIES INC) WAT (WATERS CORP)
Price698.47466.1
Market Cap55.03 Billion45.81 Billion
P/E (TTM)46.81192.6
P/B (Quarterly)28.313.056
P/S (TTM)11.88.17
Net Profit Margin (TTM)25.41.8
Gross Margin (TTM)62.749.5
ROE (TTM)71.20.8
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

IDEXX LABORATORIES INC
vs
 
WATERS CORP
 
IDEXX LABORATORIES INC
vs
 
WATERS CORP
Performance Comparison
AI Model Recommendation
IDXX · IDEXX LABORATORIES INC

Greatly Underperform

-98
UnderperformOutperform
WAT · WATERS CORP

Greatly Underperform

-95
UnderperformOutperform
Recommendation Summary

Both stocks are projected to greatly underperform the market over the next year. If you have to make a choice, Upfront Recommendation: WAT.

Financial Metrics
Prices delayed ~15 min
IDXX Metrics WAT
$698.47 Price $466.10
— Market Capitalization —
46.81 Price to Earnings Ratio 192.6
11.8 Price to Sales 8.17
42.65 Price to FCF Ratio 156.13
18.82 Price to Gross Profit 16.49
206.21 Price to R&D 123.51
36.69 Price to Current Assets 11.11

IDXX vs WAT at a glance

Idexx Laboratories INC (IDXX) and Waters Corp (WAT) are both Diagnostics & Research companies in the Healthcare sector. IDXX is the larger, at $55.0 billion in market value against $45.8 billion for WAT, about 1.2 times the size.

On trailing-twelve-month figures, IDXX trades at 46.8 times trailing earnings and WAT at 192.6; net profit margins are 25.4% and 1.8%.

The Upfront Investment model currently rates both Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.